[1]
D. D. Chaudhari and H. Mevada, “Cost-Effectiveness Analysis of Vonoprazan Vs PPIs in the Treatment of Gastroesophageal Reflux Disease”, injoere, vol. 6, no. S3, pp. 1161–1167, Jun. 2026, doi: 10.70102/mc24f350.